Romano Steven J. has filed 4 insider transactions across 2 companies since September 2024.
Most recent transaction: a grant/award of 300000 shares of Silence Therapeutics plc ($SLN) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Silence Therapeutics plc | $SLN | Romano Steven J. | EVP and Chief R&D Officer | A | Employee Share Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 141,701,848 | 9999.99% | 0.21% |
| May 22, 2025 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Romano Steven J. | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 32,125,179 | 9999.99% | 0.04% |
| Jan. 2, 2025 | Silence Therapeutics plc | $SLN | Romano Steven J. | EVP and Chief R&D Officer | A | Employee Share Option (Right to Buy) | 285000 | $0.00 | 285,000.0000 | 138,752,224 | 9999.99% | 0.21% |
| Sept. 16, 2024 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Romano Steven J. | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |